Results 1 to 10 of about 226,870 (211)

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting [PDF]

, 2016
Acknowledgements The iHARP database was funded by unrestricted grants from Mundipharma International Ltd and Research in Real-Life Ltd; these analyses were funded by an unrestricted grant from Teva Pharmaceuticals.
Bosnic-Anticevich, Sinthia, Burden, Anne, Carter, Victoria, Chrystyn, Henry, Gruffydd-Jones, Kevin, Haughney, John, Henrichsen, Svein Høegh, Hutton, Catherine, Infantino, Antonio, Lavorini, Federico, Lisspers, Karin, Papi, Alberto, Price, David B., Roche, Nicolas, Roman-Rodriguez, Miguel, Ryan, Dermot, Ställberg, Björn, Thompson, Samantha L., van der Molen, Thys, Westerik, Janine A. M.   +19 more
core   +18 more sources

The Most Common Side Effects of AstraZeneca COVID-19 Vaccine among Saudi Arabian Population: A Systematic Review

Journal of Pure and Applied Microbiology, 2023
In order to fight the coronavirus disease 2019 (COVID-19) pandemic, the AstraZeneca vaccine was introduced in the Saudi Arabian vaccination campaign. AstraZeneca was rapidly developed, and side effects have been reported following vaccination.
Jehad A. Aldali, Abdullah Abutheeb, Abdullah Al-Fahd, Meshal Alzakari, Omar Almukhalafi, Nasser Al-Tayar, Abdullah Almeziny, Razique Anwer   +7 more
doaj   +1 more source

The AstraZeneca affair. How the junk news regime affected the public debate on the COVID-19 vaccination controversy in Italy

Tecnoscienza, 2023
In recent years, there has been a notable increase in the presence of techno-scientific issues within public discourse, particularly during the COVID-19 pandemic.
Federico Pilati, Guido Anselmi
doaj   +1 more source

Determinants of healthcare workers perceptions, acceptance and choice of COVID-19 vaccines: a cross-sectional study from the United Arab Emirates

Human Vaccines & Immunotherapeutics, 2022
Acceptance of COVID-19 vaccine among health-care workers (HCWs) is crucial for controlling the pandemic and ensuring HCW and patient safety. Information on the acceptance of different COVID-19 vaccines is lacking.
Basema Saddik, Najlaa Al-Bluwi, Ankita Shukla, Hiba Barqawi, Hawra Ali Hussain Alsayed, Narjes Saheb Sharif-Askari, Mohamad-Hani Temsah, Riyad Bendardaf, Qutayba Hamid, Rabih Halwani   +9 more
doaj   +1 more source

Evaluation of immunoglobulin G level among subjects vaccinated with different types of COVID-19 vaccines in the karbala population, Iraq

Biomedical and Biotechnology Research Journal, 2022
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines represent the only way in combating the COVID-19 pandemic. Studying the differences in immune response to different types of vaccines is considered an important tool for ...
Rawaq Taleb Hassan, Suhad H Mohammed
doaj   +1 more source

Impact of previous infection and body mass index on interferon-gamma and immunoglobulin G level generated against three types of vaccines available in Iraq

Biomedical and Biotechnology Research Journal, 2022
Background: Due to increased vaccination rates and the continued spread of the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus, many people are developing “hybrid immunity” to the virus.
Rawaq Taleb Hassan, Suhad Hadi Mohammed
doaj   +1 more source

Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature

Human Vaccines & Immunotherapeutics, 2022
Mass vaccination has been the main policy to overcome the Covid-19 pandemic. Several vaccines have been approved by the World Health Organization. With growing vaccination, safety concerns and adverse events that need prompt evaluation are also emerging.
Seyed Farzad Maroufi, Fereshteh Naderi Behdani, Fatemeh Rezania, Samaneh Tanhapour Khotbehsara, Zahra Mirzaasgari   +4 more
doaj   +1 more source

A Case of Graves’ Disease Following Vaccination with the Oxford-AstraZeneca SARS-CoV-2 Vaccine: Case Report and Review of the Literature

European Journal of Case Reports in Internal Medicine, 2022
A 57-year-old man presented to the outpatient clinic with tremor, palpitations, weight loss and fatigue 1 week after receiving the first dose of the Oxford-AstraZeneca SARS-CoV-2 vaccine (ChAdOx1 nCoV-19).
Dalia Cuenca, Mercedes Aguilar-Soto, Moises Mercado   +2 more
doaj   +1 more source

A Rare Case of Guillain-Barré Syndrome following COVID-19 Vaccination

European Journal of Case Reports in Internal Medicine, 2021
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects.
Yash Kripalani, Vidyadhara Lakkappan, Lipeeka Parulekar, Anjum Shaikh, Rakesh Singh, Pradeep Vyas   +5 more
doaj   +1 more source

The first report of myocarditis followed by AstraZeneca vaccination in Iran

Chronic Diseases Journal, 2022
BACKGROUND: Coronavirus disease 2019 (COVID-19) is an emerging disease caused by the coronavirus. The initiation of vaccination significantly reduced the incidence and mortality of these patients.
Karo Servatyari, Amir Hassani
doaj   +1 more source